NCT01827865View on ClinicalTrials.gov

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Fasting
Interventions
DRUG

Etodolac Extended Release Tablets USP 600mg

Etodolac Extended Release Tablets USP 600mg once a day

DRUG

Etodolac Extended Release Tablets 600mg

Etodolac Extended Release Tablets 600mg once a day

Trial Locations (1)

380 015

Veeda Clinical Research Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY